Please assess the completion status of the following clinical trial:

Trial Title: Capsaicin to Prevent Delayed Chemotherapy Induced Nausea and Vomiting (CapCIN)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Adult chemotherapy naïve patients of at least 18 years old~2. Diagnosed with a malignant disease and scheduled for highly emetogenic chemotherapy (as defined by NCCN guidelines v1.2019)~3. No concurrent radiotherapy or use of other antiemetic drugs except (dexamethasone, ondansetron/granisetron, and olanzapine)~4. Normal renal and hepatic function~Exclusion Criteria:~1. Pregnant or breast feeding~2. Contraindication for capsaicin or other medications in the study~3. Has ongoing nausea and/or vomiting of other etiology~4. History of anticipatory nausea and/or vomiting or has vomited/nauseated within 24 hours prior to the start of scheduled chemotherapy~5. Chronic alcoholism

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Capsaicin (Type: EXPERIMENTAL): 2g of 0.075% topical capsaicin ointment applied four times daily (preferably to the abdomen) for the first five days of chemotherapy
- Placebo (Type: PLACEBO_COMPARATOR): 2g of topical placebo ointment applied four times daily (preferably to the abdomen) for the first five days of chemotherapy

Based on this trial design, predict the completion outcome and termination type (if applicable).